Biomarker testing for Personalized Therapy in real world setting; First line treatment decision in the advanced non-squamous NSCLC
Not Applicable
- Conditions
- non-squamous Non-small-cell lung carcinoma
- Registration Number
- JPRN-UMIN000030618
- Lead Sponsor
- AstraZeneca K.K.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients with postoperative recurrence 2.Patients enrolled in clinical trials of an unapproved drug as first-line therapy for advanced NSCLC 3.Patients otherwise considered unsuitable to participate in this study by investigators at study sites
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method